{"id":2575,"date":"2021-01-28T22:59:37","date_gmt":"2021-01-28T22:59:37","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=2575"},"modified":"2023-08-29T17:48:19","modified_gmt":"2023-08-29T17:48:19","slug":"pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=2575","title":{"rendered":"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14"},"content":{"rendered":"

\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)<\/a>\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9<\/a>\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002<\/p>\n

\u8be5\u516c\u53f8\u6b64\u524d\u5df2\u7ecf\u5b8c\u6210\u4e86\u83ab\u5948\u592a\u5c14\u5728\u4eba\u7c7b\u4e2d\u7684\u4e00\u671f\u8bd5\u9a8c\uff0c\u4ee5\u53ca\u5728\u76ee\u524d\u88ab\u8ba4\u4e3a\u4e0d\u53ef\u6cbb\u6108\u7684\u72ac\u6dcb\u5df4\u7624\u4e2d\u7684\u4e8c\u671f<\/a>\u548cIIa\u8bd5\u9a8c\u3002<\/p>\n

\u72ac\u7c7b\u8bd5\u9a8c\u4f7f\u7528\u7684\u662f\u6db2\u6001\u7684\u83ab\u5948\u592a\u5c14\uff0c\u867d\u7136\u6ca1\u6709\u5b89\u5168\u95ee\u9898\u7684\u62a5\u9053\uff0c\u4f46\u8be5\u914d\u65b9\u88ab\u53d1\u73b0\u96be\u4ee5\u63a5\u53d7\uff0c\u56e0\u6b64PharmAust\u5c06\u5176\u91cd\u65b0\u8bbe\u8ba1\u4e3a\u4e00\u79cd\u65b9\u4fbf\u4e14\u6613\u4e8e\u541e\u54bd\u7684\u836f\u7247\u3002<\/p>\n

\u9996\u5e2d\u79d1\u5b66\u5b98Richard Mollard\u535a\u58eb\u8bf4\uff0c\u65b0\u914d\u65b9\u89e3\u51b3\u4e86\u53e3\u5473\u95ee\u9898\uff0c\u5141\u8bb8\u5728IIa\u671f\u8bd5\u9a8c\u671f\u95f4\u663e\u8457\u589e\u52a0\u5242\u91cf\u3002<\/p>\n

\u4ed6\u8bf4:\u201c(\u8fd9\u79cd\u836f\u7247\u8ba9\u6211\u4eec)\u786e\u5b9a\u4e86\u6297\u764c\u6d3b\u6027\u6700\u5927\u5316\u7684\u6700\u4f73\u5242\u91cf\u3002\u201d<\/p>\n

\u201c\u5728\u8fd9\u4e2a\u5242\u91cf\u4e0b\uff0c\u4e00\u53ea\u72d7\u7684\u603b\u80bf\u7624\u8d1f\u62c5\u51cf\u5c11\u4e8660%\u4ee5\u4e0a\uff0c\u4e00\u4e9b\u4e2a\u4f53\u80bf\u7624\u6d88\u5931\u4e86\uff0c\u6240\u6709\u8fd9\u4e9b\u90fd\u572814\u5929\u5185(\u6240\u4ee5\u6211\u4eec\u5c06\u628a\u8fd9\u4e2a\u5242\u91cf\u5e26\u5165\u65b0\u7684IIb\u671f\u8bd5\u9a8c\u3002\u201d<\/p>\n

\u5b89\u5168\u6709\u6548\u7684<\/h2>\n

Mollard\u535a\u58eb\u8bf4\uff0c\u867d\u7136\u83ab\u5948\u592a\u5c14\u6b64\u524d\u5df2\u88ab\u517d\u533b\u6279\u51c6\u7528\u4e8e\u4e0d\u540c\u7684\u9002\u5e94\u75c7\u548c\u54c1\u79cd\uff0c\u4f46\u8be5\u516c\u53f8\u6b63\u5728\u5bfb\u6c42\u5c06\u5176\u91cd\u65b0\u7528\u4e8e\u72d7\u7c7b\u764c\u75c7\u6cbb\u7597\uff0c\u5b89\u5168\u6709\u6548\u3002<\/p>\n

\u201c\u5230\u76ee\u524d\u4e3a\u6b62\uff0c\u6211\u4eec\u5728\u60a3\u6709\u764c\u75c7\u7684\u72d7\u8eab\u4e0a\u7684\u521d\u6b65\u8bd5\u9a8c\u5df2\u7ecf\u53d6\u5f97\u4e86\u6210\u529f\uff0c\u201d\u4ed6\u8bf4\u3002<\/p>\n

\u201c\u6211\u4eec\u5f88\u9ad8\u5174\u5730\u770b\u5230\uff0c\u5728\u7b2c\u4e00\u6b21\u4f7f\u7528\u539f\u59cb\u6db2\u4f53\u914d\u65b9\u7684\u8bd5\u9a8c\u4e2d\uff0c7\u53ea\u72d7\u4e2d\u67096\u53ea\u5728\u89c4\u5b9a\u768414\u5929\u8bd5\u9a8c\u671f\u5185\u75c5\u60c5\u7a33\u5b9a\uff0c(\u540c\u6837\u6bd4\u4f8b\u7684)\u80bf\u7624\u5927\u5c0f\u4e5f\u7f29\u5c0f\u4e86\u3002\u201d<\/p>\n

\u65b0\u5357\u5a01\u5c14\u58eb\u5dde\u3001\u6606\u58eb\u5170\u5dde\u548c\u897f\u6fb3\u5927\u5229\u4e9a\u5dde\u5df2\u7ecf\u5efa\u7acb\u4e86\u517d\u533b\u8bd5\u9a8c\u4e2d\u5fc3\uff0c\u5bf9\u5c1a\u672a\u63a5\u53d7\u4efb\u4f55\u5f62\u5f0f\u6dcb\u5df4\u7624\u6cbb\u7597\u7684\u72d7\u8fdb\u884c\u836f\u7269\u8bc4\u4f30\u3002<\/p>\n

\u5728\u58a8\u5c14\u672c\u548c\u6089\u5c3c\u7684\u66f4\u591a\u8bd5\u9a8c\u70b9\u9884\u8ba1\u5c06\u4e8e\u672c\u5b63\u5ea6\u542f\u52a8\u3002<\/p>\n

\u72ac\u7c7b\u764c\u75c7<\/h2>\n

\u72ac\u7c7b\u6dcb\u5df4\u7624\u662f\u4e00\u79cd\u76f8\u5bf9\u5e38\u89c1\u7684\u764c\u75c7\uff0c\u6bcf\u5e74\u5728\u72ac\u7c7b\u65b0\u8bca\u65ad\u7684\u764c\u75c7\u4e2d\u536020%\u3002<\/p>\n

\u6700\u5e38\u89c1\u4e8e\u4e2d\u8001\u5e74\u72ac\uff0c\u75c7\u72b6\u5305\u62ec\u80bf\u80c0(\u6dcb\u5df4\u7ed3\u80bf\u5927)\u3001\u55dc\u7761\u3001\u4f53\u91cd\u51cf\u8f7b\u548c\u98df\u6b32\u4e0d\u632f\u3002<\/p>\n

\u4e00\u4e9b\u54c1\u79cd\uff0c\u5982\u91d1\u6bdb\u730e\u72ac\u3001\u6597\u725b\u7352\u72ac\u548c\u5df4\u5409\u5ea6\u730e\u72ac\u5bb9\u6613\u60a3\u764c\u75c7\uff0c\u800c\u4e14\u60a3\u75c5\u7684\u98ce\u9669\u66f4\u5927\u3002<\/p>\n

\u7814\u7a76\u8868\u660e\uff0c50%\u88ab\u8bca\u65ad\u4e3aB\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72d7\u5728\u4e0d\u63a5\u53d7\u6cbb\u7597\u7684\u60c5\u51b5\u4e0b\u53ef\u4ee5\u5b58\u6d3b30\u5929\u5de6\u53f3\uff0c\u800c50%\u7684\u72d7\u4f1a\u7ecf\u5386\u66f4\u957f\u671f\u7684\u8fdb\u5c55\u3002<\/p>\n

\u76ee\u524d\uff0c\u6700\u597d\u7684\u6cbb\u7597\u9009\u62e9\u662f\u5316\u7597\uff0c\u4f46\u5373\u4f7f\u5728\u8fd9\u79cd\u6cbb\u7597\u4e4b\u540e\uff0c12\u4e2a\u6708\u5185\u590d\u53d1\u4e5f\u5e76\u4e0d\u7f55\u89c1\u3002<\/p>\n

PharmAust\u7684IIb\u671f\u4e34\u5e8a\u8bd5\u9a8c\u65e8\u5728\u4e3a\u72d7\u4e3b\u4eba\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7597\u9009\u62e9\uff0c\u7ec8\u70b9\u662f\u80bf\u7624\u7a33\u5b9a\u6216\u6d88\u5931\u3002<\/p>\n

\u5408\u683c\u6807\u51c6<\/h2>\n

\u8981\u83b7\u5f97PharmAust IIb\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53c2\u8d5b\u8d44\u683c\uff0c\u72d7\u53ef\u4ee5\u60a3\u6709\u4efb\u4f55\u9636\u6bb5\u7684\u6dcb\u5df4\u7624\uff0c\u4f46\u5fc5\u987b\u8eab\u4f53\u72b6\u51b5\u826f\u597d\u3002<\/p>\n

Mollard\u535a\u58eb\u8bf4\uff0c\u514d\u75ab\u8868\u578b\u2014\u2014\u5373\u5bf9\u764c\u75c7\u662fB\u7ec6\u80de\u8fd8\u662fT\u7ec6\u80de\u7c7b\u578b\u7684\u5206\u6790\u2014\u2014\u5c06\u4f5c\u4e3a\u521d\u59cb\u7b5b\u67e5\u7684\u4e00\u90e8\u5206\u3002<\/p>\n

\u5176\u4ed6\u8d44\u683c\u6807\u51c6\u5305\u62ec\u4f53\u91cd\u8d85\u8fc711\u516c\u65a4;\u826f\u597d\u7684\u751f\u6d3b\u8d28\u91cf\uff0c\u6ca1\u6709\u5176\u4ed6\u91cd\u5927\u7684\u548c\u5e76\u53d1\u7684\u533b\u7597\u95ee\u9898\u3002<\/p>\n

\u4e3b\u4eba\u5fc5\u987b\u80fd\u591f\u628a\u4ed6\u4eec\u7684\u72d7\u9001\u5230\u8bd5\u9a8c\u4e2d\u5fc3\uff0c\u5e76\u613f\u610f\u4e3a\u8bca\u65ad\u652f\u4ed8\u521d\u6b65\u54a8\u8be2\u8d39\u7528\u3002<\/p>\n

\u4e00\u65e6\u5ba0\u7269\u88ab\u8bca\u65ad\u4e3a\u6dcb\u5df4\u7624\uff0cPharmAust\u5c06\u627f\u62c5\u6240\u6709\u7684\u4e34\u5e8a\u8bd5\u9a8c\u8d39\u7528(\u5305\u62ec\u5f80\u8fd4\u8bd5\u9a8c\u4e2d\u5fc3\u7684\u65c5\u8d39)\u4ee5\u53ca\u8bd5\u9a8c\u540e\u7684\u7ef4\u6301\u6cbb\u7597(\u5982\u679c\u8ba4\u4e3a\u6709\u76ca)\u3002<\/p>\n

\u83ab\u5948\u592a\u5c14\u5e73\u677f\u7535\u8111\u5c06\u5728\u5bb6\u4e2d\u4f7f\u7528\uff0c\u8bd5\u7528\u671f\u95f4\u7528\u6237\u5c06\u88ab\u8981\u6c42\u4fdd\u5b58\u4e00\u4e2a\u7b80\u5355\u7684\u65e5\u5fd7\u3002<\/p>\n

\u8fdb\u4e00\u6b65\u7684\u4fe1\u606f<\/h2>\n

\u6709\u5174\u8da3\u4e3a\u72d7\u53ea\u62a5\u540d\u53c2\u52a0\u8bd5\u9a8c\u7684\u5ba0\u7269\u4e3b\u4eba\uff0c\u5e94\u4e0e\u517d\u533b\u8054\u7edc\uff0c\u4ee5\u83b7\u5f97\u8fdb\u4e00\u6b65\u8d44\u6599\u53ca\u8f6c\u4ecb\u81f3\u6700\u8fd1\u7684\u8bd5\u9a8c\u4e2d\u5fc3\u3002<\/p>\n

\u76ee\u524d\u7684\u8bd5\u9a8c\u4e2d\u5fc3\u8bbe\u5728\u52a8\u7269\u8f6c\u8bca\u533b\u9662Animal Referral Hospital(\u6089\u5c3c);\u897f\u6fb3\u517d\u533b\u5e94\u6025\u548c\u4e13\u4e1aVeterinary Emergency and Specialty(Success);\u73c0\u65af\u517d\u533b\u4e13\u5bb6Veterinary Specialists(Osborne Park);\u52a8\u7269\u8f6c\u8bca\u533b\u9662Animal Referral Hospital(\u5e03\u91cc\u65af\u73ed);\u548cVeterinary Specialist Services (\u5e03\u91cc\u65af\u73ed)\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002 \u8be5\u516c\u53f8\u6b64\u524d\u5df2\u7ecf\u5b8c\u6210\u4e86\u83ab\u5948\u592a\u5c14\u5728\u4eba\u7c7b\u4e2d\u7684\u4e00\u671f\u8bd5\u9a8c\uff0c\u4ee5\u53ca\u5728\u76ee\u524d\u88ab\u8ba4\u4e3a\u4e0d\u53ef\u6cbb\u6108\u7684\u72ac\u6dcb\u5df4\u7624\u4e2d\u7684\u4e8c\u671f\u548cIIa\u8bd5\u9a8c\u3002 \u72ac\u7c7b\u8bd5\u9a8c\u4f7f\u7528\u7684\u662f\u6db2\u6001\u7684\u83ab\u5948\u592a\u5c14\uff0c\u867d\u7136\u6ca1\u6709\u5b89\u5168\u95ee\u9898\u7684\u62a5\u9053\uff0c\u4f46\u8be5\u914d\u65b9\u88ab\u53d1\u73b0\u96be\u4ee5\u63a5\u53d7\uff0c\u56e0\u6b64PharmAust\u5c06\u5176\u91cd\u65b0\u8bbe\u8ba1\u4e3a\u4e00\u79cd\u65b9\u4fbf\u4e14\u6613\u4e8e\u541e\u54bd\u7684\u836f\u7247\u3002 \u9996\u5e2d\u79d1\u5b66\u5b98Richard Mollard\u535a\u58eb\u8bf4\uff0c\u65b0\u914d\u65b9\u89e3\u51b3\u4e86\u53e3\u5473\u95ee\u9898\uff0c\u5141\u8bb8\u5728IIa\u671f\u8bd5\u9a8c\u671f\u95f4\u663e\u8457\u589e\u52a0\u5242\u91cf\u3002 \u4ed6\u8bf4:\u201c(\u8fd9\u79cd\u836f\u7247\u8ba9\u6211\u4eec)\u786e\u5b9a\u4e86\u6297\u764c\u6d3b\u6027\u6700\u5927\u5316\u7684\u6700\u4f73\u5242\u91cf\u3002\u201d \u201c\u5728\u8fd9\u4e2a\u5242\u91cf\u4e0b\uff0c\u4e00\u53ea\u72d7\u7684\u603b\u80bf\u7624\u8d1f\u62c5\u51cf\u5c11\u4e8660%\u4ee5\u4e0a\uff0c\u4e00\u4e9b\u4e2a\u4f53\u80bf\u7624\u6d88\u5931\u4e86\uff0c\u6240\u6709\u8fd9\u4e9b\u90fd\u572814\u5929\u5185(\u6240\u4ee5\u6211\u4eec\u5c06\u628a\u8fd9\u4e2a\u5242\u91cf\u5e26\u5165\u65b0\u7684IIb\u671f\u8bd5\u9a8c\u3002\u201d \u5b89\u5168\u6709\u6548\u7684 Mollard\u535a\u58eb\u8bf4\uff0c\u867d\u7136\u83ab\u5948\u592a\u5c14\u6b64\u524d\u5df2\u88ab\u517d\u533b\u6279\u51c6\u7528\u4e8e\u4e0d\u540c\u7684\u9002\u5e94\u75c7\u548c\u54c1\u79cd\uff0c\u4f46\u8be5\u516c\u53f8\u6b63\u5728\u5bfb\u6c42\u5c06\u5176\u91cd\u65b0\u7528\u4e8e\u72d7\u7c7b\u764c\u75c7\u6cbb\u7597\uff0c\u5b89\u5168\u6709\u6548\u3002 \u201c\u5230\u76ee\u524d\u4e3a\u6b62\uff0c\u6211\u4eec\u5728\u60a3\u6709\u764c\u75c7\u7684\u72d7\u8eab\u4e0a\u7684\u521d\u6b65\u8bd5\u9a8c\u5df2\u7ecf\u53d6\u5f97\u4e86\u6210\u529f\uff0c\u201d\u4ed6\u8bf4\u3002 \u201c\u6211\u4eec\u5f88\u9ad8\u5174\u5730\u770b\u5230\uff0c\u5728\u7b2c\u4e00\u6b21\u4f7f\u7528\u539f\u59cb\u6db2\u4f53\u914d\u65b9\u7684\u8bd5\u9a8c\u4e2d\uff0c7\u53ea\u72d7\u4e2d\u67096\u53ea\u5728\u89c4\u5b9a\u768414\u5929\u8bd5\u9a8c\u671f\u5185\u75c5\u60c5\u7a33\u5b9a\uff0c(\u540c\u6837\u6bd4\u4f8b\u7684)\u80bf\u7624\u5927\u5c0f\u4e5f\u7f29\u5c0f\u4e86\u3002\u201d \u65b0\u5357\u5a01\u5c14\u58eb\u5dde\u3001\u6606\u58eb\u5170\u5dde\u548c\u897f\u6fb3\u5927\u5229\u4e9a\u5dde\u5df2\u7ecf\u5efa\u7acb\u4e86\u517d\u533b\u8bd5\u9a8c\u4e2d\u5fc3\uff0c\u5bf9\u5c1a\u672a\u63a5\u53d7\u4efb\u4f55\u5f62\u5f0f\u6dcb\u5df4\u7624\u6cbb\u7597\u7684\u72d7\u8fdb\u884c\u836f\u7269\u8bc4\u4f30\u3002 \u5728\u58a8\u5c14\u672c\u548c\u6089\u5c3c\u7684\u66f4\u591a\u8bd5\u9a8c\u70b9\u9884\u8ba1\u5c06\u4e8e\u672c\u5b63\u5ea6\u542f\u52a8\u3002 \u72ac\u7c7b\u764c\u75c7 \u72ac\u7c7b\u6dcb\u5df4\u7624\u662f\u4e00\u79cd\u76f8\u5bf9\u5e38\u89c1\u7684\u764c\u75c7\uff0c\u6bcf\u5e74\u5728\u72ac\u7c7b\u65b0\u8bca\u65ad\u7684\u764c\u75c7\u4e2d\u536020%\u3002 \u6700\u5e38\u89c1\u4e8e\u4e2d\u8001\u5e74\u72ac\uff0c\u75c7\u72b6\u5305\u62ec\u80bf\u80c0(\u6dcb\u5df4\u7ed3\u80bf\u5927)\u3001\u55dc\u7761\u3001\u4f53\u91cd\u51cf\u8f7b\u548c\u98df\u6b32\u4e0d\u632f\u3002 \u4e00\u4e9b\u54c1\u79cd\uff0c\u5982\u91d1\u6bdb\u730e\u72ac\u3001\u6597\u725b\u7352\u72ac\u548c\u5df4\u5409\u5ea6\u730e\u72ac\u5bb9\u6613\u60a3\u764c\u75c7\uff0c\u800c\u4e14\u60a3\u75c5\u7684\u98ce\u9669\u66f4\u5927\u3002 \u7814\u7a76\u8868\u660e\uff0c50%\u88ab\u8bca\u65ad\u4e3aB\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72d7\u5728\u4e0d\u63a5\u53d7\u6cbb\u7597\u7684\u60c5\u51b5\u4e0b\u53ef\u4ee5\u5b58\u6d3b30\u5929\u5de6\u53f3\uff0c\u800c50%\u7684\u72d7\u4f1a\u7ecf\u5386\u66f4\u957f\u671f\u7684\u8fdb\u5c55\u3002 \u76ee\u524d\uff0c\u6700\u597d\u7684\u6cbb\u7597\u9009\u62e9\u662f\u5316\u7597\uff0c\u4f46\u5373\u4f7f\u5728\u8fd9\u79cd\u6cbb\u7597\u4e4b\u540e\uff0c12\u4e2a\u6708\u5185\u590d\u53d1\u4e5f\u5e76\u4e0d\u7f55\u89c1\u3002 PharmAust\u7684IIb\u671f\u4e34\u5e8a\u8bd5\u9a8c\u65e8\u5728\u4e3a\u72d7\u4e3b\u4eba\u63d0\u4f9b\u66f4\u591a\u7684\u6cbb\u7597\u9009\u62e9\uff0c\u7ec8\u70b9\u662f\u80bf\u7624\u7a33\u5b9a\u6216\u6d88\u5931\u3002 \u5408\u683c\u6807\u51c6 \u8981\u83b7\u5f97PharmAust IIb\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u53c2\u8d5b\u8d44\u683c\uff0c\u72d7\u53ef\u4ee5\u60a3\u6709\u4efb\u4f55\u9636\u6bb5\u7684\u6dcb\u5df4\u7624\uff0c\u4f46\u5fc5\u987b\u8eab\u4f53\u72b6\u51b5\u826f\u597d\u3002 Mollard\u535a\u58eb\u8bf4\uff0c\u514d\u75ab\u8868\u578b\u2014\u2014\u5373\u5bf9\u764c\u75c7\u662fB\u7ec6\u80de\u8fd8\u662fT\u7ec6\u80de\u7c7b\u578b\u7684\u5206\u6790\u2014\u2014\u5c06\u4f5c\u4e3a\u521d\u59cb\u7b5b\u67e5\u7684\u4e00\u90e8\u5206\u3002 \u5176\u4ed6\u8d44\u683c\u6807\u51c6\u5305\u62ec\u4f53\u91cd\u8d85\u8fc711\u516c\u65a4;\u826f\u597d\u7684\u751f\u6d3b\u8d28\u91cf\uff0c\u6ca1\u6709\u5176\u4ed6\u91cd\u5927\u7684\u548c\u5e76\u53d1\u7684\u533b\u7597\u95ee\u9898\u3002 \u4e3b\u4eba\u5fc5\u987b\u80fd\u591f\u628a\u4ed6\u4eec\u7684\u72d7\u9001\u5230\u8bd5\u9a8c\u4e2d\u5fc3\uff0c\u5e76\u613f\u610f\u4e3a\u8bca\u65ad\u652f\u4ed8\u521d\u6b65\u54a8\u8be2\u8d39\u7528\u3002 \u4e00\u65e6\u5ba0\u7269\u88ab\u8bca\u65ad\u4e3a\u6dcb\u5df4\u7624\uff0cPharmAust\u5c06\u627f\u62c5\u6240\u6709\u7684\u4e34\u5e8a\u8bd5\u9a8c\u8d39\u7528(\u5305\u62ec\u5f80\u8fd4\u8bd5\u9a8c\u4e2d\u5fc3\u7684\u65c5\u8d39)\u4ee5\u53ca\u8bd5\u9a8c\u540e\u7684\u7ef4\u6301\u6cbb\u7597(\u5982\u679c\u8ba4\u4e3a\u6709\u76ca)\u3002 \u83ab\u5948\u592a\u5c14\u5e73\u677f\u7535\u8111\u5c06\u5728\u5bb6\u4e2d\u4f7f\u7528\uff0c\u8bd5\u7528\u671f\u95f4\u7528\u6237\u5c06\u88ab\u8981\u6c42\u4fdd\u5b58\u4e00\u4e2a\u7b80\u5355\u7684\u65e5\u5fd7\u3002 \u8fdb\u4e00\u6b65\u7684\u4fe1\u606f \u6709\u5174\u8da3\u4e3a\u72d7\u53ea\u62a5\u540d\u53c2\u52a0\u8bd5\u9a8c\u7684\u5ba0\u7269\u4e3b\u4eba\uff0c\u5e94\u4e0e\u517d\u533b\u8054\u7edc\uff0c\u4ee5\u83b7\u5f97\u8fdb\u4e00\u6b65\u8d44\u6599\u53ca\u8f6c\u4ecb\u81f3\u6700\u8fd1\u7684\u8bd5\u9a8c\u4e2d\u5fc3\u3002 \u76ee\u524d\u7684\u8bd5\u9a8c\u4e2d\u5fc3\u8bbe\u5728\u52a8\u7269\u8f6c\u8bca\u533b\u9662Animal Referral Hospital(\u6089\u5c3c);\u897f\u6fb3\u517d\u533b\u5e94\u6025\u548c\u4e13\u4e1aVeterinary Emergency and Specialty(Success);\u73c0\u65af\u517d\u533b\u4e13\u5bb6Veterinary Specialists(Osborne Park);\u52a8\u7269\u8f6c\u8bca\u533b\u9662Animal Referral Hospital(\u5e03\u91cc\u65af\u73ed);\u548cVeterinary Specialist Services (\u5e03\u91cc\u65af\u73ed)\u3002<\/p>\n","protected":false},"author":4,"featured_media":10645,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[241],"yoast_head":"\nPharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14<\/title>\n<meta name=\"description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14\" \/>\n<meta property=\"og:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-28T22:59:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:48:19+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/PharmAust-PAA-ASX-canine-participants-Phase-IIb-lymphoma-trial-drug-monepantel.jpg\" \/>\n<meta name=\"author\" content=\"Imelda Cotton\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14\" \/>\n<meta name=\"twitter:description\" content=\"\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/PharmAust-PAA-ASX-canine-participants-Phase-IIb-lymphoma-trial-drug-monepantel.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Imelda Cotton\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/\",\"name\":\"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-01-28T22:59:37+00:00\",\"dateModified\":\"2023-08-29T17:48:19+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\"},\"description\":\"\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e\",\"name\":\"Imelda Cotton\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g\",\"caption\":\"Imelda Cotton\"},\"description\":\"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=4\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14","description":"\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14","og_description":"\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/","og_site_name":"smallcapsCN","article_published_time":"2021-01-28T22:59:37+00:00","article_modified_time":"2023-08-29T17:48:19+00:00","og_image":[{"url":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/PharmAust-PAA-ASX-canine-participants-Phase-IIb-lymphoma-trial-drug-monepantel.jpg"}],"author":"Imelda Cotton","twitter_card":"summary_large_image","twitter_title":"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14","twitter_description":"\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2021\/01\/PharmAust-PAA-ASX-canine-participants-Phase-IIb-lymphoma-trial-drug-monepantel.jpg","twitter_misc":{"Written by":"Imelda Cotton"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/","url":"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/","name":"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-01-28T22:59:37+00:00","dateModified":"2023-08-29T17:48:19+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e"},"description":"\u751f\u7269\u6280\u672f\u516c\u53f8PharmAust (ASX: PAA)\u6b63\u5728\u5bfb\u6c42\u62db\u52df\u66f4\u591a\u60a3\u6709b\u7ec6\u80de\u6dcb\u5df4\u7624\u7684\u72ac\u53ea\uff0c\u53c2\u4e0e\u4e00\u9879\u65b0\u7684IIb\u671f\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5176\u9886\u5148\u6297\u764c\u836f\u7269\u83ab\u5948\u592a\u5c14\u7684\u91cd\u65b0\u914d\u65b9\uff0c\u8be5\u836f\u7269\u5df2\u88ab\u8bc1\u660e\u5bf9\u5c1a\u672a\u63a5\u53d7\u764c\u75c7\u6cbb\u7597\u7684\u72ac\u53ea\u6709\u6548\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/pharmaust-canine-participants-phase-iib-lymphoma-trial-drug-monepantel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"PharmAust\u5bfb\u6c42\u66f4\u591a\u7684\u72ac\u7c7b\u53c2\u4e0eIIb\u671f\u6dcb\u5df4\u7624\u8bd5\u9a8c\uff0c\u4f7f\u7528\u94c5\u836f\u7269\u83ab\u5948\u592a\u5c14"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/cb7c1f9e2fb318e8ea5882e380e0d90e","name":"Imelda Cotton","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/171e68cb4a3261dde883daa03441bfa3?s=96&d=mm&r=g","caption":"Imelda Cotton"},"description":"Imelda Cotton has over 20 years experience as a journalist and communications professional. She has spent the bulk of her career in the resources sector, having also worked directly with oil and gas majors and as a journalist covering a vast array of ASX listed companies within the resources, energy, science and health sectors.","url":"https:\/\/smallcapscn.x5view.co\/?author=4"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2575"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2575"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2575\/revisions"}],"predecessor-version":[{"id":10644,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/2575\/revisions\/10644"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/10645"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}